Significant technological advances

Some pharma companies have diversified into biotechnology and some start-up companies engaged exclusively in biotech have achieved a significant level of success, particularly in vaccines, enzymes, monoclonal antibodies, GN-CSF (Filgrastin), Erythropoietin, Streptokinasae, Taxol derivatives, anti-ulcer drugs and bioinformatics. For instance, I would like to mention vaccine products such as tetanus, rabies, oral polio vaccine, measles, hepatitis BDPT, BCG, diphtheria toxoid, interferon, and so on produced in India in this period. In addition, animal vaccines are also being produced in large quantity. It is a fact that India is uniquely positioned in the global vaccine market, being the world’s largest producer and accounting for approximately one third of the global sales. It is believed that India will emerge as the largest supplier of vaccines and some other biotech products all over the world in the years to come.

This entry was posted on Tuesday, April 10th, 2007 at 6:25 am and is filed under India. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.